Skip to main content
Premium Trial:

Request an Annual Quote

EMBL Group, Flemish Institutes Launch Open-Source Proteomics Database

NEW YORK, Aug. 30 (GenomeWeb News) - A consortium of research institutes and universities in the UK and Belgium has launched the Proteomics Identifications Database, an open-source proteomics database, the groups said this week.


Members of the consortium include the European Bioinformatics Institute, part of the European Molecular Biology Laboratory, in Hinxton, UK; and Flanders Interuniversity Institute for Biotechnology and Ghent University, both in Belgium.


The database, called PRIDE for short, includes results of the Human Proteome Organization's Plasma Proteome Project, and a human platelet proteome set published by Ghent University.


The results of other international collaborations such as HUPO's Liver Proteome Project will follow after they are published, the consortium said.


The PRIDE database, source code, data, and support tools are freely available for web access or download, and can be found here.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.